Stem cell transplantation increases antioxidant effects in diabetic mice

International Journal of Biological Sciences

Volumn 8, Issue 10, 2012, Pages 1335-1344

  Li, Ming ^a   Vanella, L ^b   Zhang, Yuming ^c   Shi, Ming ^a   Takaki, Takashi ^d   Shapiro, Joseph I ^b   Ikehara, Susumu ^a  

^a KANSAI MEDICAL UNIVERSITY   (Japan)

^b MARSHALL UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c FIRST MILITARY MEDICAL UNIVERSITY   (China)

^d JEOL LTD   (Japan)

Author keywords

Antioxidant; Diabetic nephropathy; HO 1; IBM BMT+TT

Indexed keywords

ANTIOXIDANT; HEME OXYGENASE 1; INSULIN; NITRIC OXIDE SYNTHASE; PROTEIN KINASE B; PROTEIN SERINE THREONINE KINASE; STK11 PROTEIN, MOUSE;

ANIMAL; ARTICLE; BODY WEIGHT; BONE MARROW TRANSPLANTATION; EXPERIMENTAL DIABETES MELLITUS; GENETICS; GLUCOSE BLOOD LEVEL; KIDNEY; LYMPHOCYTE; METABOLISM; MOUSE; PANCREAS; PATHOLOGY; PHOSPHORYLATION; PHYSIOLOGY; STEM CELL TRANSPLANTATION; THYMUS; TRANSPLANTATION; UPREGULATION;

ANIMALS; ANTIOXIDANTS; BLOOD GLUCOSE; BODY WEIGHT; BONE MARROW TRANSPLANTATION; DIABETES MELLITUS, EXPERIMENTAL; HEME OXYGENASE-1; INSULIN; KIDNEY; LYMPHOCYTES; MICE; NITRIC OXIDE SYNTHASE; PANCREAS; PHOSPHORYLATION; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS C-AKT; STEM CELL TRANSPLANTATION; THYMUS GLAND; UP-REGULATION;

MUS;

EID: 84869744849     PISSN: 14492288     EISSN: None     Source Type: Journal    
DOI: 10.7150/ijbs.4654     Document Type: Article

References (43)

1. Otterbein LE, Soares MP, Yamashita K, Bach FH. Heme oxygenase-1: unleashing the protective properties of heme. Trends Immunol. 2003; 24: 449-455.
2. Orozco LD, Kapturczak MH, Barajas B, Wang X, Weinstein MM, Wong J, et al. Heme oxygenase-1 expression in macrophages plays a beneficial role in atherosclerosis. Circ Res. 2007; 100: 1703-1711.
3. Goulmy E, Schipper R, Pool J, Blokland E, Falkenburg JH, Vossen J, et al. Mismatches of minor histocompatibility antigens between HLA-identical donors and recipients and the development of graft-versus-host disease after bone marrow transplantation. N Engl J Med. 1996; 334: 281-285.
4. Ikehara S. A novel strategy for allogeneic stem cell transplantation: perfusion method plus intra-bone marrow injection of stem cells. Exp Hematol. 2003; 31: 1142-1146.
5. Nakamura K, Inaba M, Sugiura K, Yoshimura T, Kwon AH, Kamiyama Y, et al. Enhancement of allogeneic hematopoietic stem cell engraftment and prevention of GVHD by intra-bone marrow bone marrow transplantation plus donor lymphocyte infusion. Stem Cells. 2004; 22: 125-134.
6. Hosaka N, Nose M, Kyogoku M, Nagata N, Miyashima S, Good RA, et al. Thymus transplantation, a critical factor for correction of autoimmune disease in aging MRL/+mice. Proc Natl Acad Sci U S A. 1996; 93: 8558-8562.
7. Li M, Abraham NG, Vanella L, Zhang Y, Inaba M, Hosaka N, et al. Successful modulation of type 2 diabetes in db/db mice with intra-bone marrow--bone marrow transplantation plus concurrent thymic transplantation. J Autoimmun. 2010; 35: 414-423.
8. Breyer MD, Bottinger E, Brosius FC, 3rd, Coffman TM, Harris RC, Heilig CW, et al. Mouse models of diabetic nephropathy. J Am Soc Nephrol. 2005; 16: 27-45.
9. Ziyadeh FN, Hoffman BB, Han DC, Iglesias-De La Cruz MC, Hong SW, Isono M, et al. Long-term prevention of renal insufficiency, excess matrix gene expression, and glomerular mesangial matrix expansion by treatment with monoclonal antitransforming growth factor-beta antibody in db/db diabetic mice. Proc Natl Acad Sci U S A. 2000; 97: 8015-8020.
10. Ritz E, Tarng DC. Renal disease in type 2 diabetes. Nephrol Dial Transplant. 2001; 16 Suppl 5: 11-8.
11. Baynes JW. Role of oxidative stress in development of complications in diabetes. Diabetes. 1991; 40: 405-412.
12. Kakimoto M, Inoguchi T, Sonta T, Yu HY, Imamura M, Etoh T, et al. Accumulation of 8-hydroxy-2'-deoxyguanosine and mitochondrial DNA deletion in kidney of diabetic rats. Diabetes. 2002; 51: 1588-1595.
13. Abraham NG, Li M, Vanella L, Peterson SJ, Ikehara S, Asprinio D. Bone marrow stem cell transplant into intra-bone cavity prevents type 2 diabetes: role of heme oxygenase-adiponectin. J Autoimmun. 2008; 30:128-35.
14. Toki J, Adachi Y, Jin T, Fan T, Takase K, Lian Z, et al. Enhancement of IL-7 following irradiation of fetal thymus. Immunobiology. 2003; 207: 247-258.
15. Li M, Kim DH, Tsenovoy PL, Peterson SJ, Rezzani R, Rodella LF, et al. Treatment of obese diabetic mice with a heme oxygenase inducer reduces visceral and subcutaneous adiposity, increases adiponectin levels, and improves insulin sensitivity and glucose tolerance. Diabetes. 2008; 57: 1526-1535.
16. Peterson SJ, Kim DH, Li M, Positano V, Vanella L, Rodella LF, et al. The L-4F mimetic peptide prevents insulin resistance through increased levels of HO-1, pAMPK, and pAKT in obese mice. J Lipid Res. 2009; 50: 1293-1304.
17. Chua SC, Jr., Chung WK, Wu-Peng XS, Zhang Y, Liu SM, Tartaglia L, et al. Phenotypes of mouse diabetes and rat fatty due to mutations in the OB (leptin) receptor. Science. 1996; 271: 994-996.
18. Fantuzzi G, Faggioni R. Leptin in the regulation of immunity, inflammation, and hematopoiesis. J Leukoc Biol. 2000; 68: 437-446.
19. Matarese G, Moschos S, Mantzoros CS. Leptin in immunology. J Immunol. 2005; 174: 3137-3142.
20. Fernandes G, Handwerger BS, Yunis EJ, Brown DM. Immune response in the mutant diabetic C57BL/Ks-dt+ mouse. Discrepancies between in vitro and in vivo immunological assays. J Clin Invest. 1978; 61: 243-250.
21. Kimura M, Tanaka S, Isoda F, Sekigawa K, Yamakawa T, Sekihara H. T lymphopenia in obese diabetic (db/db) mice is non-selective and thymus independent. Life Sci. 1998; 62: 1243-1250.
22. Flaquer M, Franquesa M, Barquinero J, Lloberas N, Gutierrez C, Torras J, et al. Bone marrow transplantation induces normoglycemia in a type 2 diabetes mellitus murine model. Transplant Proc. 2009; 41: 2282-2285.
23. Amiri F, Shaw S, Wang X, Tang J, Waller JL, Eaton DC, et al. Angiotensin II activation of the JAK/STAT pathway in mesangial cells is altered by high glucose. Kidney Int. 2002; 61: 1605-1616.
24. Marrero MB, Banes-Berceli AK, Stern DM, Eaton DC. Role of the JAK/STAT signaling pathway in diabetic nephropathy. Am J Physiol Renal Physiol. 2006; 290: F762-F768.
25. Schulz E, Dopheide J, Schuhmacher S, Thomas SR, Chen K, Daiber A, et al. Suppression of the JNK pathway by induction of a metabolic stress response prevents vascular injury and dysfunction. Circulation. 2008; 118: 1347-1357.
26. Abraham NG, Cao J, Sacerdoti D, Li X, Drummond G. Heme oxygenase: the key to renal function regulation. Am J Physiol Renal Physiol. 2009; 297: F1137-F1152.
27. Elmarakby AA, Faulkner J, Baban B, Saleh MA, Sullivan JC. Induction of hemeoxygenase-1 reduces glomerular injury and apoptosis in diabetic spontaneously hypertensive rats. Am J Physiol Renal Physiol. 2012; 302: F791-F800.
28. Vanella L, Sanford C, Jr., Kim DH, Abraham NG, Ebraheim N. Oxidative stress and heme oxygenase-1 regulated human mesenchymal stem cells differentiation. Int J Hypertens. 2012; 2012: 890671.
29. Gerbitz A, Ewing P, Wilke A, Schubert T, Eissner G, Dietl B, et al. Induction of heme oxygenase-1 before conditioning results in improved survival and reduced graft-versus-host disease after experimental allogeneic bone marrow transplantation. Biol Blood Marrow Transplant. 2004; 10: 461-472.
30. Cheng C, Noorderloos M, van Deel ED, Tempel D, den Dekker W, Wagtmans K, et al. Dendritic cell function in transplantation arteriosclerosis is regulated by heme oxygenase 1. Circ Res. 2010; 106: 1656-1666.
31. Sharma K, Ramachandrarao S, Qiu G, Usui HK, Zhu Y, Dunn SR, et al. Adiponectin regulates albuminuria and podocyte function in mice. J Clin Invest. 2008; 118: 1645-1656.
32. Ouchi N, Kobayashi H, Kihara S, Kumada M, Sato K, Inoue T, et al. Adiponectin stimulates angiogenesis by promoting cross-talk between AMP-activated protein kinase and Akt signaling in endothelial cells. J Biol Chem. 2004; 279: 1304-1309.
33. Ito T, Suzuki A, Imai E, Okabe M, Hori M. Bone marrow is a reservoir of repopulating mesangial cells during glomerular remodeling. J Am Soc Nephrol. 2001; 12: 2625-2635.
34. Wong CY, Cheong SK, Mok PL, Leong CF. Differentiation of human mesenchymal stem cells into mesangial cells in post-glomerular injury murine model. Pathology. 2008; 40: 52-57.
35. Sugimoto H, Mundel TM, Sund M, Xie L, Cosgrove D, Kalluri R. Bone-marrow-derived stem cells repair basement membrane collagen defects and reverse genetic kidney disease. Proc Natl Acad Sci USA. 2006; 103: 7321-7326.
36. Lange C, Togel F, Ittrich H, Clayton F, Nolte-Ernsting C, Zander AR, et al. Administered mesenchymal stem cells enhance recovery from ischemia/reperfusion-induced acute renal failure in rats. Kidney Int. 2005; 68: 1613-7.
37. Morigi M, Imberti B, Zoja C, Corna D, Tomasoni S, Abbate M, et al. Mesenchymal stem cells are renotropic, helping to repair the kidney and improve function in acute renal failure. J Am Soc Nephrol. 2004; 15: 1794-1804.
38. Anglani F, Forino M, Del Prete D, Tosetto E, Torregrossa R, D'Angelo A. In search of adult renal stem cells. J Cell Mol Med. 2004; 8: 474-487.
39. Kalluri R, Shield CF, Todd P, Hudson BG, Neilson EG. Isoform switching of type IV collagen is developmentally arrested in X-linked Alport syndrome leading to increased susceptibility of renal basement membranes to endoproteolysis. J Clin Invest. 1997; 99: 2470-2478.
40. Hudson BG, Tryggvason K, Sundaramoorthy M, Neilson EG. Alport's syndrome, Goodpasture's syndrome, and type IV collagen. N Engl J Med. 2003; 348: 2543-2556.
41. Hakim FT, Gress RE. Immunosenescence: deficits in adaptive immunity in the elderly. Tissue Antigens. 2007; 70: 179-189.
42. Linton PJ, Dorshkind K. Age-related changes in lymphocyte development and function. Nat Immunol. 2004; 5: 133-139.
43. Aspinall R. Age-associated thymic atrophy in the mouse is due to a deficiency affecting rearrangement of the TCR during intrathymic T cell development. J Immunol. 1997; 158: 3037-3045.